about
Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver FibrosisDrug Discovery Targeting Bromodomain-Containing Protein 4.ETS-targeted therapy: can it substitute for MEK inhibitors?The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart.Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy.Pyruvate dehydrogenase kinase regulates hepatitis C virus replication.High fat diet-induced changes of mouse hepatic transcription and enhancer activity can be reversed by subsequent weight loss.BET inhibitors block pancreatic stellate cell collagen I production and attenuate fibrosis in vivo.Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosisTargeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer.Epigenetic regulation of cardiac fibrosis.BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance.Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation.BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.Epigenetics and Liver Fibrosis.BRD4 inhibition for the treatment of pathological organ fibrosisHepatic stellate cells as key target in liver fibrosis.BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation.BRD4 inhibitors block telomere elongation.Epigenetic reprogramming in liver fibrosis and cancer.Pharmacological targeting of BET proteins attenuates radiation-induced lung fibrosis.Biology and Mechanisms of Action of the Vitamin D Hormone.RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation.Benefit of Apabetalone on Plasma Proteins in Renal Disease.Epigenetic Regulation of Myofibroblast Phenotypes in FibrosisCXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosisEpigenetics in Cardiac Fibrosis: Emphasis on Inflammation and Fibroblast Activation
P2860
Q28070012-51C5A77C-871E-4BE6-955E-E10B7EA5F92BQ30352390-3B3FFAFE-454D-425C-82D4-9B48743DF86EQ33638827-17E57942-1280-4338-8EF4-856341E8F0D7Q33737254-F15C996B-4830-4269-B86C-E6198A1224C9Q36410973-108D4ADB-C526-4F45-B1AD-20412FB704E5Q37137222-D673B009-F20B-42D8-8131-924656416CE6Q37575928-0DAA548E-1DE4-4425-9CFA-16F068D391ACQ37624355-5ECA0233-B850-4651-9226-881549AA5854Q37688355-C1BC6130-96E1-439B-90AA-B0568263D73EQ38708376-79BA0613-7DCA-4C9C-BCEB-C4AD44806D89Q38733315-0AA671A8-A5F7-4C58-BFBD-8D7F721AA6C0Q38776637-E91D725D-2164-4B93-95DC-7A70DD6C53C1Q38970003-1A923A5B-CFF1-4C54-B327-7B388E6884B4Q39236663-0535CE50-A9C7-4E70-8F67-91DAF99FCC5FQ39358760-37A13F1B-9213-4636-A4AC-B2457B92C12FQ39442981-3DB667C5-7C85-42C3-AFF1-A79DCE2C761AQ40200602-5F39174E-80BC-41E6-8471-D59FA5410057Q41255959-4AB469F8-6742-47F7-A92C-2F8A60415B44Q42321605-8EBF0797-9667-48AB-8B01-36F54D418741Q42512025-9DE0C618-34C9-4740-9E8E-8F0F7651EEF4Q47136781-65DC80DF-F665-4FE5-934A-B2EA9044370BQ47157566-9F93B005-2AE1-4147-9E03-ACB8B59CE581Q48223411-A9E9FA66-2B32-44FC-BCF5-930960561AF7Q50101275-63BA9E52-74C1-4C8A-BFCC-8AD481F68402Q52573450-7F8EAA54-2D2D-4265-A075-06DA1893834EQ55316265-D5A8628B-37B5-4916-9DEB-036BCF8C8E58Q57147732-07BB8A93-DFB1-4825-B9C5-E73E2CC166FDQ58779664-8FA54CA8-9F2E-4CCD-9787-96A64B5B26C9Q59136748-E012E380-B6CC-4FB5-B1C7-B5BD9736D95F
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
BRD4 is a novel therapeutic target for liver fibrosis.
@ast
BRD4 is a novel therapeutic target for liver fibrosis.
@en
type
label
BRD4 is a novel therapeutic target for liver fibrosis.
@ast
BRD4 is a novel therapeutic target for liver fibrosis.
@en
prefLabel
BRD4 is a novel therapeutic target for liver fibrosis.
@ast
BRD4 is a novel therapeutic target for liver fibrosis.
@en
P2093
P2860
P356
P1476
BRD4 is a novel therapeutic target for liver fibrosis.
@en
P2093
Christopher Liddle
Mara H Sherman
Mathias Leblanc
Michael Downes
Mingxiao He
P2860
P304
15713-15718
P356
10.1073/PNAS.1522163112
P407
P577
2015-12-07T00:00:00Z